ALL
-
-
Aug 26, 2021 stock
-
-
stock
-
Notice Regarding Completion of Payment Concerning Disposal of Treasury Stock as Restricted Stock Compensation(141 KB)
-
-
Aug 16, 2021 product/service
-
-
product/service
-
Notice Regarding Marketing Approvals for 1 Ingredient / 1 Product of Generic Drugs for KYOSOMIRAI PHARMA(147 KB)
-
-
Aug 06, 2021 performance
-
-
performance
-
Summary of Consolidated Financial Results for the First Quarter of Fiscal Year Ending March 31, 2022(379 KB)
-
-
Aug 02, 2021 product/service
-
-
product/service
-
Notice RegardingLaunch of 1 Ingredient/ 2 Products of Generic Drugs for KYOSOMIRAI PHARMA(110 KB)
-
-
Jul 27, 2021 stock
-
-
stock
-
Notice Regarding Disposal of Treasury Stock as Restricted Stock Compensation(201 KB)
-
-
Jun 30, 2021 other
-
-
other
-
Regarding a judgment on the violation of the Antimonopoly Act(58 KB)
-
-
Jun 29, 2021 corporate
-
-
corporate
-
Notice Regarding Change of Corporate Officers and Executive Appointment(165 KB)
-
-
Jun 18, 2021 product/service
-
-
product/service
-
Notice Regarding Launch of 3 Ingredients/ 6 Products of Generic Drugs for KYOSOMIRAI PHARMA(139 KB)
-
-
Jun 16, 2021 M&A/partnership
-
-
M&A/partnership
-
Notice Regarding Agreement for Business Alliance with Morimoto-Pharma Co., Ltd.(77 KB)
-
-
Jun 16, 2021 product/service
-
-
product/service
-
Notice Regarding Approval of Partial Amendments to Indications, Dosage and Administration of DULOXETINE Capsules 20mg/30mg “KMP” for KYOSOMIRAI PHARMA(126 KB)
-
-
May 26, 2021 M&A/partnership
-
-
M&A/partnership
-
Notice Regarding Business Succession by a Subsidiary(116 KB)
-
-
May 26, 2021 M&A/partnership
-
-
M&A/partnership
-
Notice Regarding Underwriting of Capital Increase Through Third-Party Allotment Conducted by HAPINE Life Ikkou Corporation(131 KB)
-
-
May 25, 2021 corporate
-
-
corporate
-
Notice Regarding Change of Representative Director(142 KB)
-
-
May 14, 2021 performance
-
-
performance
-
Summary of Consolidated Financial Results of Fiscal Year Ended March 31, 2021(1 MB)
